Current Atherosclerosis Reports

, Volume 4, Issue 2, pp 107–112

Alcohol: Lipid metabolism and cardioprotection

  • Henry J. Pownall


The decision to consume alcohol is associated with risks and benefits that vary according to family history (genes) and environment. The risk for coronary heart disease (CHD) is reduced in populations that regularly consume moderate amounts of alcohol. The risk reduction is associated with increased plasma high-density lipoprotein (HDL) cholesterol. Predisposing factors may make some individuals more vulnerable to alcohol-related risks than others. For example, individuals with hypertriglyceridemia and a personal or family history of pancreatitis might consider the benefits of alcohol consumption not worth the health risks. The risks might be more acceptable to someone with a family history of CHD, normal plasma triglyceride levels, low HDL cholesterol, and no personal or family history of addictive behavior or pancreatitis. An understanding of the metabolic effects of alcohol and a careful study of personal and family histories should permit physicians and their patients to make informed decisions about the risks and benefits of alcohol consumption.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Block G, Dresser CM, Hartman AM, et al.: Nutrient sources in the American diet: quantitative data from the NHANES II survey. II. Macronutrients and fats. Am J Epidemiol 1985, 122:27–40.PubMedGoogle Scholar
  2. 2.
    Block G, Subar AF: Estimates of nutrient intake from a food frequency questionnaire: the 1987 National Health Interview Survey. J Am Diet Assoc 1992, 92:969–977.PubMedGoogle Scholar
  3. 3.
    Thun MJ, Peto R, Lopez AD, et al.: Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997, 337:1705–1714.PubMedCrossRefGoogle Scholar
  4. 4.
    Camargo CA, Hennekens CH, Gaziano JM, et al.: Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med 1997, 157:79–85.PubMedCrossRefGoogle Scholar
  5. 5.
    Berger K, Ajani UA, Kase CS, et al.: Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med 1999, 341:1557–1564.PubMedCrossRefGoogle Scholar
  6. 6.
    Rimm EB, Williams P, Fosher K, et al.: Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999, 319:1523–1528.PubMedGoogle Scholar
  7. 7.
    Makela P, Valkonen T, Poikolainen K, et al.: Estimated numbers of deaths from coronary heart disease “caused” and “prevented” by alcohol: an example from Finland. J Stud Alcohol 1997, 58:455–463.PubMedGoogle Scholar
  8. 8.
    Rehm J, Greenfield TK, Rogers JD, et al.: Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey. Am J Epidemiol 2001, 153:64–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Valmadrid CT, Klein R, Moss SE, et al.: Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA 1999, 282:239–246.PubMedCrossRefGoogle Scholar
  10. 10.
    Gronbaek M, Becker U, Johansen D, et al.: Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000, 133:411–419.PubMedGoogle Scholar
  11. 11.
    Saxena UL, Witte D, Goldberg IJ: Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 1989, 264:4349–4355.PubMedGoogle Scholar
  12. 12.
    Crouse JR, Gerson CD, DeCarli LM, et al.: Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. J Lipid Res 1968, 9:509–512.PubMedGoogle Scholar
  13. 13.
    Pownall HJ: Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins. J Lipid Res 1994, 35:2105–2113.PubMedGoogle Scholar
  14. 14.
    Nilsson NO, Belfrage P: Effects of acetate, acetaldehyde, and ethanol on lipolysis in isolated rat adipocytes. J Lipid Res 1978, 19:737–741.PubMedGoogle Scholar
  15. 15.
    Siler SQ, Neese RA, Hellerstein MK: De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. Am J Clin Nutr 1999, 70:928–936.PubMedGoogle Scholar
  16. 16.
    Patsch JR, Miesenbock G, Hopferwieser T, et al.: Relationship of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arteriosclerosis Thromb 1992, 12:1336–1345.Google Scholar
  17. 17.
    van Tol A, Groener JE, Scheek LM, et al.: Induction of net mass lipid transfer reactions in plasma by wine consumption with dinner. Eur J Clin Invest 1995, 25:390–395.PubMedGoogle Scholar
  18. 18.
    van Tol A, van der Gaag MS, Scheek LM, et al.: Changes in postprandial lipoproteins of low and high density caused by moderate alcohol consumption with dinner. Atherosclerosis 1998, 141(suppl. 1):S101–103.PubMedGoogle Scholar
  19. 19.
    Hendriks HF, Veenstra J, van Tol A, et al.: Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition. Alcohol 1998, 33:403–410.Google Scholar
  20. 20.
    Riemens SC, van Tol A, Hoogenberg K, et al.: Higher high density lipoprotein cholesterol associated with moderate alcohol consumption is not related to altered plasma lecithin:cholesterol acyltransferase and lipid transfer protein activity levels. Clin Chem Acta 1997, 258:105–115.CrossRefGoogle Scholar
  21. 21.
    Pownall HJ, Ballantyne CM, Kimball KT, et al.: Effect of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state. Arch Intern Med 1999, 159:981–987.PubMedCrossRefGoogle Scholar
  22. 22.
    Christiansen C, Thomsen C, Rasmussen O, et al.: The acute impact of ethanol on glucose, insulin, triacylglycerol, and free fatty acid responses and insulin sensitivity in type 2 diabetes. Br J Nutr 1996, 76:669–675.PubMedCrossRefGoogle Scholar
  23. 23.
    Zhong S, Sharp DS, Grove JS, et al.: Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996, 97:2917–2923.PubMedCrossRefGoogle Scholar
  24. 24.
    van der Gaag MS, van Tol A, Scheek LM, et al.: Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 1999, 147:405–410.PubMedCrossRefGoogle Scholar
  25. 25.
    Sane T, Nikkila EA, Taskinen MR, et al.: Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol. Atherosclerosis 1984, 53:185–193.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • Henry J. Pownall
    • 1
  1. 1.Baylor College of MedicineHoustonUSA

Personalised recommendations